PAPER Wang W, Zhang J, Li C

Randomized controlled trial of bushen yinao pill combined with conventional therapy on intestinal flora imbalance and cognitive function improvement in older patients with Alzheimer's disease.

Int J Psychiatry Med. 2024 Dec 12;:912174241290962. Epub 2024 Dec 12 PubMed.

PAPER Eng S, Aifuwa E, Frishman WH, Aronow WS

Cardiovascular Effect of Drugs Used to Treat Alzheimer's Disease.

Cardiol Rev. 2024 Dec 12; Epub 2024 Dec 12 PubMed.

PAPER Qiu C, Xu H

A Six-Gene Signature Related to Liquid-Liquid Phase Separation for Diagnosis of Alzheimer's Disease.

Actas Esp Psiquiatr. 2024 Dec;52(6):759-768. PubMed.

PAPER Liu Q, Wang H, Lv S, Zhao Y, Zheng Y, Li G, Wang W

The Combined Use of Levodopa/Benserazide and Pramipexole Proves Beneficial for Managing Parkinson's Disease.

Actas Esp Psiquiatr. 2024 Dec;52(6):769-776. PubMed.

PAPER Solomon B, Voronov-Goldman M

Amyloid-β is NOT only the most promising target for Alzheimer's disease.

Neural Regen Res. 2024 Dec 7; Epub 2024 Dec 7 PubMed.

PAPER Di Stefano J, Di Marco F, Cicalini I, FitzGerald U, Pieragostino D, Verhoye M, Ponsaerts P, Van Breedam E

Generation, interrogation, and future applications of microglia-containing brain organoids.

Neural Regen Res. 2024 Dec 7; Epub 2024 Dec 7 PubMed.

PAPER Yi LX, Woon HR, Saw G, Zeng L, Tan EK, Zhou ZD

Induced pluripotent stem cell-related approaches to generate dopaminergic neurons for Parkinson's disease.

Neural Regen Res. 2025 Nov 1;20(11):3193-3206. Epub 2024 Dec 7 PubMed.

PAPER Ritchie DL, Smith C

Pathological spectrum of sporadic Creutzfeldt-Jakob disease.

Pathology. 2025 Mar;57(2):196-206. Epub 2024 Nov 13 PubMed.

PAPER Maass F, Canaslan S, van Riesen C, Hermann P, Schmitz M, Schulte C, Brockmann K, Synofzik M, Bähr M, Zerr I

Myelin basic protein and TREM2 quantification in the CSF of patients with Multiple System Atrophy and other Parkinsonian conditions.

J Neurol. 2024 Dec 12;272(1):52. PubMed.

PAPER Wang C, Wang S, Zhou C, Wu C, Yang S, Xu X, Zhang M, Huang P

LRRK2 mutation contributes to decreased free water in the nucleus basalis of Meynert in manifest and premanifest Parkinson's disease.

J Neurol. 2024 Dec 12;272(1):33. PubMed.

PAPER Zimmermann M, Mengel D, Raupach K, Haack T, Neumann M, Synofzik M

Frequency and neuropathology of HTT repeat expansions in FTD/ALS: co-existence rather than causation.

J Neurol. 2024 Dec 12;272(1):58. PubMed.

PAPER Eratne D, Li QX, Lewis C, Dang C, Kang MJ, Grewal J, Loi S, Walterfang M, Evans AH, Malpas CB, Pedrini S, Martins R, Chatterjee P, Zetterberg H, Blennow K, Berkovic SF, Santillo AF, Collins S, Masters CL, Velakoulis D, MiND Study Group

Strong diagnostic performance of plasma ptau217 for CSF biomarker-defined young-onset Alzheimer disease in a diagnostically heterogeneous clinical cohort.

J Neurol. 2024 Dec 12;272(1):25. PubMed.

PAPER van Eijk RP, van Loon FT, van Unnik JW, Weemering DN, Seitidis G, Mavridis D, van den Berg LH, Nikolakopoulos S

Attrition and discontinuation in amyotrophic lateral sclerosis clinical trials: a meta-analysis.

J Neurol. 2024 Dec 12;272(1):40. PubMed.

PAPER Shim SR, Kim JY, Kwon KY, Shin J, Lee Y, Lee SM

Effects of rivastigmine on gait in patients with neurodegenerative disorders: A systematic review and meta-analysis.

PLoS One. 2024;19(12):e0310900. Epub 2024 Dec 12 PubMed.

PAPER Yang X, Fan Z, Li Z, Zhou J

Resting-state EEG microstate features for Alzheimer's disease classification.

PLoS One. 2024;19(12):e0311958. Epub 2024 Dec 12 PubMed.